Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil, methylphenidate and aminophylline for weaning from mechanical ventilation in acute traumatic brain injury
IRCT20130719014056N14Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of modafinil, methylphenidate and aminophylline in traumatic brain injury (TBI) and respiratory failure (3 arms), sponsored by Arak University of Medical Sciences. Started Aug 2024; status: completed.
02
Drugs
modafinilmethylphenidateaminophylline
03
Conditions
traumatic brain injury (TBI)respiratory failure
Beyond the preview
Go deeper on IRCT20130719014056N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130719014056N14.